Robert R. Goodwin
Corporate Officer/Principal bij Takeda Vaccines (Montana), Inc.
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Donald P. Beeman | M | - |
LigoCyte Pharmaceuticals, Inc.
Takeda Vaccines (Montana), Inc.
Takeda Vaccines (Montana), Inc. Pharmaceuticals: MajorHealth Technology Takeda Vaccines (Montana), Inc. operates as a biopharmaceutical company which focuses on the development of vaccines that prevent human infectious diseases. It specializes in developing vaccines against norovirus, influenza, and respiratory syncytial virus. The firm develops norovirus VLP vaccines that mimic the surface configuration of the live virus without the ability to cause infection, respiratory syncytial virus vaccine that mediates cell entry in its native form for use in anthrax treatment. The company was founded by Robert F. Bargatze on March 13, 2008 and is headquartered in Bozeman, MT. | - |
Robert F. Bargatze | M | - |
LigoCyte Pharmaceuticals, Inc.
Takeda Vaccines (Montana), Inc.
Takeda Vaccines (Montana), Inc. Pharmaceuticals: MajorHealth Technology Takeda Vaccines (Montana), Inc. operates as a biopharmaceutical company which focuses on the development of vaccines that prevent human infectious diseases. It specializes in developing vaccines against norovirus, influenza, and respiratory syncytial virus. The firm develops norovirus VLP vaccines that mimic the surface configuration of the live virus without the ability to cause infection, respiratory syncytial virus vaccine that mediates cell entry in its native form for use in anthrax treatment. The company was founded by Robert F. Bargatze on March 13, 2008 and is headquartered in Bozeman, MT. | 26 jaar |
Larry W. Mikkola | M | - |
LigoCyte Pharmaceuticals, Inc.
Takeda Vaccines (Montana), Inc.
Takeda Vaccines (Montana), Inc. Pharmaceuticals: MajorHealth Technology Takeda Vaccines (Montana), Inc. operates as a biopharmaceutical company which focuses on the development of vaccines that prevent human infectious diseases. It specializes in developing vaccines against norovirus, influenza, and respiratory syncytial virus. The firm develops norovirus VLP vaccines that mimic the surface configuration of the live virus without the ability to cause infection, respiratory syncytial virus vaccine that mediates cell entry in its native form for use in anthrax treatment. The company was founded by Robert F. Bargatze on March 13, 2008 and is headquartered in Bozeman, MT. | - |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Ivor Royston | M | 79 |
LigoCyte Pharmaceuticals, Inc.
| 4 jaar |
Benjamin Auspitz | M | 51 |
LigoCyte Pharmaceuticals, Inc.
| - |
Markus Goebel | M | - |
LigoCyte Pharmaceuticals, Inc.
| - |
Paul M. Mendelman | M | 76 |
LigoCyte Pharmaceuticals, Inc.
| - |
Charles Richardson | M | 72 |
LigoCyte Pharmaceuticals, Inc.
| 12 jaar |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Verenigde Staten | 8 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Robert R. Goodwin
- Persoonlijk netwerk